Plasma exchange combined with bortezomib-based chemotherapy is effective for early renal recovery in a patient with IgD-λ type multiple myeloma
Open Access
- 23 January 2020
- journal article
- case report
- Published by Springer Nature in CEN Case Reports
- Vol. 9 (2) , 165-172
Abstract
The immunoglobulin (Ig) D type is a rare variant of multiple myeloma (MM), that accounts for 1–2% of all cases. Compared to the more common types of MM, IgD MM is known to have more severe symptoms at presentation, and a poorer prognosis. A woman was admitted to our hospital for severe acute kidney disease and disorder (AKD) and back pain, and was started on hemodialysis. The renal biopsy revealed light chain cast nephropathy. She was diagnosed with IgD-λ MM based on Bence-Jones protein expression and high IgD serum levels, and started bortezomib therapy with plasma exchange (PE). After three sessions of PE, the serum free light chain levels decreased by 92%, and she was withdrawn from dialysis. The patient underwent autologous transplantation and is still in remission, demonstrating the benefits of a bortezomib-based regimen in combination with PE for IgD MM with AKD.Keywords
This publication has 14 references indexed in Scilit:
- Effect of High-Cutoff Hemodialysis vs Conventional Hemodialysis on Hemodialysis Independence Among Patients With Myeloma Cast NephropathyJAMA, 2017
- Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patientsNephrology Dialysis Transplantation, 2015
- Clinicopathologic Correlations in Multiple Myeloma: A Case Series of 190 Patients With Kidney BiopsiesAmerican Journal of Kidney Diseases, 2012
- Early Reduction of Serum-Free Light Chains Associates with Renal Recovery in Myeloma KidneyJournal of the American Society of Nephrology, 2011
- Outcome of Patients With IgD and IgM Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Retrospective CIBMTR StudyClinical Lymphoma Myeloma and Leukemia, 2010
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.Journal of Clinical Oncology, 1994
- Prognostic factors in IgD myeloma: A study of 21 casesScandinavian Journal of Haematology, 1984
- IgD Multiple MyelomaArchives of internal medicine (1960), 1975
- Younger Age of Presentation and Extraosseous Tumour in IgD MyelomatosisBMJ, 1969